Registry for patients with Chronic Lymphocytic Leukemia in Turkey
Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study
This study is looking at how patients with Chronic Lymphocytic Leukemia in Turkey are treated and managed to see what works best, especially for those with a specific genetic change.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Izmir Hematologic Diseases and Cancer Research Help Association Academic / other |
| Locations | 1 site (Izmir) |
| Trial ID | NCT03197259 on ClinicalTrials.gov |
What this trial studies
This is a multicenter, prospective observational study aimed at understanding the real-world management and treatment history of patients diagnosed with Chronic Lymphocytic Leukemia (CLL) across 25 centers in Turkey. The study will gather data on the effectiveness of various therapeutic strategies used in both community and academic settings. By analyzing this information, the study seeks to provide valuable insights into the management of CLL, particularly for patients with the del(17P) genetic alteration.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who have been diagnosed with Chronic Lymphocytic Leukemia.
Not a fit: Patients younger than 18 years will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of Chronic Lymphocytic Leukemia, leading to better treatment outcomes for patients.
How similar studies have performed: While this study is observational and focuses on real-world data, similar studies have shown success in providing insights into the management of chronic conditions, suggesting potential for valuable findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed as CLL * 18 years or older * Able and willing to provide the written informed consent Exclusion Criteria: * Younger than 18 years
Where this trial is running
Izmir
- Dokuz Eylum Medical Favulty — Izmir, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Fatih Demirkan, Prof — Dokuz Eylum Medical Faculty
- Study coordinator: Fatih Demirkan, Prof
- Email: fatihdemirkan@yahoo.com
- Phone: +90 542 515 17 80
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.